Mersana Therapeutics (MRSN) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-4.87
-3.28
-1.68
-0.09

Details

Expected EPS
-3.865
Actual EPS
-4.87
Surprise EPS
-1.01
Surprise Percent
+26%

Description

Mersana Therapeutics (MRSN) has reported earnings of -4.87 per share for Q3 2025.

0 Comments

Share your thoughts